NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH), a clinical-stage biotechnology company developing an innovative ...
Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications The provisional patent application describes novel nanoparticle ...
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (RAPH), a clinical-stage biotechnology company developing an innovative research platform based on cannabinoids free of THC and ...
The company achieved the unique flaky texture of fish using its proprietary 3D printing technology combined with custom-made bio-inks REHOVOT, Israel, Nov. 16, 2022 /PRNewswire/ -- Steakholder Foods ...
LegalZoom Launches Streamlined Provisional Patent Filing Product to Help Businesses and Entrepreneurs Protect Intellectual Property, Secure Funding and Drive Growth LegalZoom’s law firm to provide ...
Many startup companies are formed around new ideas and inventions. Therefore, protecting such innovations may be extremely important, especially early on. If your business plan includes foreign ...
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH) , a clinical-stage biotechnology company developing an innovative ...
Patent applicants often file provisional applications at the United States Patent and Trademark Office (USPTO) to secure a priority date before filing a full-blown utility patent application for their ...
Incannex Healthcare Limited IXHL IHL, announced the filing of a provisional patent application directed to the use of IHL-42X for the treatment of obstructive sleep apnea (‘OSA’). With this latest ...
NEW YORK , Nov. 12, 2020 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced the ...
You have an invention you want to patent. To qualify in most countries, your invention must meet the standard for so-called absolute novelty. This means it cannot have been sold or disclosed in prior ...